| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 24.713 | 0 | 0 | 1.274 | 1.029 | 1.033 | 490 | 1.627 | 3.002 | 2.253 |
| Total Income - EUR | 28.088 | 0 | 109 | 1.274 | 1.029 | 1.248 | 570 | 1.629 | 3.126 | 2.263 |
| Total Expenses - EUR | 29.541 | 203 | 160 | 8.175 | 6.549 | 8.219 | 7.984 | 7.208 | 10.561 | 9.995 |
| Gross Profit/Loss - EUR | -1.453 | -203 | -51 | -6.901 | -5.519 | -6.970 | -7.414 | -5.580 | -7.436 | -7.732 |
| Net Profit/Loss - EUR | -1.453 | -203 | -54 | -6.940 | -5.530 | -6.982 | -7.420 | -5.596 | -7.466 | -7.755 |
| Employees | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Interpharm Bio Cosmetics Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 1.946 | 3.903 | 3.829 | 2.600 | 2.608 | 2.600 | 2.586 |
| Current Assets | 2.549 | 6.085 | 5.960 | 1.461 | 1.537 | 1.509 | 1.303 | 1.021 | 3.693 | 526 |
| Inventories | 0 | 4.899 | 4.816 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 2.169 | 914 | 1.033 | 1.099 | 1.323 | 1.313 | 1.216 | 992 | 865 | 138 |
| Cash | 381 | 272 | 111 | 362 | 214 | 196 | 88 | 28 | 2.828 | 387 |
| Shareholders Funds | -15.857 | -17.159 | -16.923 | -23.552 | -28.626 | -35.065 | -41.708 | -47.433 | -54.756 | -62.205 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 18.406 | 23.244 | 22.883 | 26.959 | 34.065 | 40.403 | 45.611 | 51.062 | 61.049 | 65.316 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2042 - 2042" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Interpharm Bio Cosmetics Srl